Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Camptosar

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
The aim of this work is the in vitro and ex vivo assessment of the leishmanicidal activity of camptothecin and three analogues… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
2009
2009
e15114 Background: In a previous study, IFL was used in patients (pt) with untreated metastatic colon cancer and a median overall… Expand
2008
2008
Purpose: To assess the pharmacokinetics, tumor drug accumulation, and therapeutic activity of Irinophore C, a novel liposomal… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Review
2007
Review
2007
Current treatment modalities for cancer combine cytotoxic drugs against DNA and novel targeted drugs affecting signal… Expand
2006
2006
Erlotinib (Tarceva®, OSI-774) is a potent, orally available, small-molecule inhibitor of HER1/EGFR tyrosine-kinase activity. In… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Review
2006
Review
2006
Thirty-one patients with metastatic colorectal cancer were enrolled in this phase I/II trial of a triple combination of camptosar… Expand
2005
2005
A simple, rapid and sensitive LC-MS/MS bioanalytical method has been developed to simultaneously quantify Camptosar (CPT-11) and… Expand
2000
2000
The United States Food and Drug Administration (FDA) has adopted its accelerated approval regulation as a means of expediting the… Expand
  • table 1
  • table 2
  • table 3
Highly Cited
1999
Highly Cited
1999
Angiogenesis has been correlated with increased invasion and metastases in a variety of human neoplasms. Inadequate inhibition of… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
1998
1998
A method for the detection of the photodegradation products of irinotecan (CPT-11, Campto, Camptosar) was developed using high… Expand